Those costs are nonsense. Look at the costs for the 2 very large trials that cassava did and they were no where close to $300m and they took 30 months.
And there is no chance that CM sells shares at 2.25. He will run the relatively inexpensive schizophrenia trials and sell the company for $50 per share if it came to that.
Market Data 
Markets 
AI
